Income and Expenditure
The Leprosy Mission Australia (TLMA) has achieved a surplus for the 2021 financial year of $805,030 (2020: $13,926), which includes a non-monetary adjustment of $390,487, to reflect its Financial Assets at its fair value at year end.
We are thankful to our supporters who have contributed so generously towards helping people affected by leprosy under very challenging circumstances with the COVID-19 pandemic.
We are thankful for the faithful and generous giving of our donors which saw income go up by 14% to $6,771,437 which has been the highest revenue achieved since 2014. This included a grant of $1,004,066 from the Department of Foreign Affairs and Trade (DFAT).
Through stringent cost savings and restructuring together with support of our donors and DFAT, TLMA
has increased its support to international projects by 13% to seven countries around the world– India, Indonesia, Nepal, Nigeria, Papua New Guinea, Timor-Leste, and Thailand.
Where did we get that money?
TLMA has 4 main sources of income – donations from individuals including churches and groups, merchandise sales, government grants from Department of Foreign Affairs and Trade (DFAT) and investment income. Against last year, all income sources performed well, monetary donation increased 22% as generous donors responded urgently to the needs of leprosy affected people during this COVID crisis and our commercial (merchandise) income also increased 41% due to faithful and generous donors who have supported us by buying merchandise from our shop.
Percentage values calculated based on the Audited TLMA Financial Statements for the year ended 30 June 2021.
These summary financial statements have been prepared in accordance with the requirements set out in the ACFID Code of Conduct. For further information on the Code, please refer to the ACFID website www.acfid.asn.au.
For a copy of The Leprosy Mission Australia (TLMA) full audited financial statements
or further information, please contact our team on 1800 537 767 or visit our website www.leprosymission.org.au
Where did we spend it?
Disbursements of DFAT grant increased in line with what was received and with the support of our faithful and generous donors, we managed to increase our funding to our international projects in the seven countries for the financial year. The increased funding was to support our leprosy hospitals to be equipped to support COVID patients including those suffering from leprosy and to provide emergency assistance to those impacted by COVID and natural disasters, for example the floods in Timor-Leste. This has ensured that timely and adequate aid was provided to effectively help the affected communities, especially those affected by leprosy and disabilities.
Our overall financial health
TLMA has a strong balance sheet with adequate reserves on hand. This is monitored by management on a regular basis to ensure we can continue to offer sustainable support to our overseas projects in the long term. Therefore, our financial objectives are to continue to look for ways to improve our revenue sources to build and sustain the Company’s capability to meet our project commitments and navigate through the various challenges posed by this COVID-19 pandemic. To do this, we will continue to keep a tight control spending on non-project expenditure and to work together with our generous supporters and partners to continue support to our projects, whilst maximising our efficient and effective use of resources.